{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:15Z","timestamp":1783181115346,"version":"3.54.6"},"reference-count":73,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cardiovasc Pharmacol Ther"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Antiplatelet therapy is a cornerstone in coronary artery disease management. However, patients with acute coronary syndrome still remain at risk of recurrent cardiovascular events despite the advance of medical therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This article provides a review of antiplatelet agents used in cardiovascular diseases and focus on updates in the past 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Peer-reviewed clinical trials and relevant treatment guidelines were identified from MEDLINE and Current Content database (from 1966 to April 15, 2013) using search terms aspirin, clopidogrel, prasugrel, ticagrelor, glycoprotein IIb\/IIIa inhibitors, antiplatelet agents, coronary artery disease, acute coronary syndrome, pharmacology, pharmacokinetics, and pharmacodynamics. Citations from the available articles were also reviewed for additional references.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In unstable angina and non-ST-segment elevation myocardial infarction (MI), dual antiplatelet therapy (aspirin and clopidogrel) demonstrated a reduction in death from cardiovascular causes, nonfatal MI, or stroke (relative risk 0.80; 95% confidence interval [CI], 0.72-0.90). In ST-segment elevation MI, dual antiplatelet therapy reduced the rate of occluded infarct-related artery\/death or recurrent MI (95% CI, 24%-47%). Newer agents such as prasugrel, when compared to clopidogrel, reduced death from vascular causes, MI, or stroke in patients undergoing percutaneous coronary intervention (PCI; hazard ratio [HR], 0.81; 95% CI 0.73-0.90) but not in those receiving medical management only. When compared to clopidogrel, ticagrelor reduces death from vascular causes, MI, or stroke (HR: 0.84; 95% CI, 0.77-0.92) in patients undergoing PCI or receiving medical management only. Both the agents, however, increase the risk of bleeding in certain patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In the last 5 years, newer antiplatelet agents, including prasugrel and ticagrelor, have been demonstrated to reduce recurrent cardiovascular events compared to standard therapy and, however, also caused increase bleeding in selected patient populations. Newer agents including shorter acting P2Y12 inhibitor or antiplatelets that target other receptors are being evaluated to improve\/maintain therapeutic efficacy yet minimize the risk of bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1074248413499971","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T08:19:53Z","timestamp":1383898793000},"page":"514-524","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Updates in Antiplatelet Agents Used in Cardiovascular Diseases"],"prefix":"10.1177","volume":"18","author":[{"given":"Judy W. M.","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"bibr1-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071014"},{"key":"bibr2-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318282ab8f"},{"key":"bibr3-1074248413499971","unstructured":"2012 ACCF\/AHA Focused Update Incorporated Into the ACC\/AHA 2007 Guidelines for the Management of Patients With Unstable Angina\/Non-ST Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation\/American Heart association Task Force on Practice Guidelines; 2013. http:\/\/circ.ahajournals.org\/content\/127\/23\/e663.full.pdf+html. Accessed July 2, 2013."},{"key":"bibr4-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6"},{"key":"bibr5-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"bibr6-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"bibr7-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050522"},{"key":"bibr8-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67660-X"},{"key":"bibr9-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2293"},{"key":"bibr10-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411083111902"},{"key":"bibr11-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-007-0053-0"},{"key":"bibr12-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"bibr13-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.04.006"},{"key":"bibr14-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.628"},{"key":"bibr15-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.959239"},{"key":"bibr16-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2012.07071.x"},{"key":"bibr17-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm248"},{"key":"bibr18-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000020190.45892.75"},{"key":"bibr19-1074248413499971","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00008"},{"issue":"6","key":"bibr20-1074248413499971","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/dc10-0555","volume":"33","author":"Pignone M","year":"2010","journal-title":"Diabetes Care"},{"key":"bibr21-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.169"},{"key":"bibr22-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1757"},{"key":"bibr23-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.17.1680"},{"key":"bibr24-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl472"},{"issue":"11","key":"bibr25-1074248413499971","first-page":"1360","volume":"27","author":"Vickers S","year":"1999","journal-title":"vitro and in vivo studies on the metabolism of tirofiban"},{"key":"bibr26-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v138.a100465"},{"key":"bibr27-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp376"},{"key":"bibr28-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008904310194"},{"key":"bibr29-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"bibr30-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03400-0"},{"key":"bibr31-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901316"},{"key":"bibr32-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03763.x"},{"key":"bibr33-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-869523"},{"key":"bibr34-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614133"},{"issue":"2","key":"bibr35-1074248413499971","first-page":"15","volume":"25","author":"Savcic M","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"bibr36-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160869.75810.98"},{"key":"bibr37-1074248413499971","doi-asserted-by":"crossref","unstructured":"von Beckerath N, Taubert D, Pogatsa-Murray G, Sch\u00f6mig E, Kastrati A, Sch\u00f6mig A. Absorption, metabolization, and antiplatelet effects of 300- 600- and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (intracoronary stenting and antithrombotic regimen: choose between 3 high oral doses for immediate clopidogrel effect) trial.\n                      Circulation\n                      . 2005;112(19):2946\u20132950.","DOI":"10.1161\/CIRCULATIONAHA.105.559088"},{"key":"bibr38-1074248413499971","doi-asserted-by":"crossref","unstructured":"Cuisset T, Frere C, Quilici J, Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomesin patients with non-ST-segment elevation acute coronary syndromeundergoing coronary stenting.\n                      J Am Coll Cardiol\n                      . 2006;48(7):1339\u20131345.","DOI":"10.1016\/j.jacc.2006.06.049"},{"key":"bibr39-1074248413499971","doi-asserted-by":"crossref","unstructured":"Montalescot G, Sideris G, Meuleman C, ALBION Trial Investigators. A randomized comparison of high clopidogrel Cheng 9 loading doses in patients with non-ST-segment elevation acutecoronary syndromes: the ALBION (assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis) trial.\n                      J Am Coll Cardiol\n                      .  2006;48(5):931\u2013938.","DOI":"10.1016\/j.jacc.2006.04.090"},{"key":"bibr40-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014522"},{"key":"bibr41-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03714.x"},{"key":"bibr42-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi877"},{"key":"bibr43-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007309709"},{"key":"bibr44-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.10.010"},{"key":"bibr45-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"bibr46-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1586\/erc.09.172"},{"key":"bibr47-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.1993.tb00275.x"},{"key":"bibr48-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1160\/THS10-12-0769"},{"key":"bibr49-1074248413499971","unstructured":"Brilinta\u2122 prescribing information; 2012. http:\/\/www1.astrazeneca-us.com\/pi\/brilinta.pdf. Accessed January 5, 2012."},{"key":"bibr50-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.032250"},{"key":"bibr51-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"issue":"9621","key":"bibr52-1074248413499971","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","volume":"371","author":"Wiviott SD","year":"2008","journal-title":"Lancet"},{"issue":"16","key":"bibr53-1074248413499971","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott SD","year":"2008","journal-title":"Circulation"},{"key":"bibr54-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60441-4"},{"key":"bibr55-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.851949"},{"key":"bibr56-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205512"},{"key":"bibr57-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"bibr58-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.07.015"},{"issue":"19","key":"bibr59-1074248413499971","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica BM","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"bibr60-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62191-7"},{"key":"bibr61-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3527"},{"key":"bibr62-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.029"},{"key":"bibr63-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.927582"},{"key":"bibr64-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.933796"},{"key":"bibr65-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq325"},{"key":"bibr66-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1586\/erc.09.101"},{"key":"bibr67-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-869525"},{"key":"bibr68-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908629"},{"key":"bibr69-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300815"},{"key":"bibr70-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp504"},{"key":"bibr71-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1021\/jm0502236"},{"key":"bibr72-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109719"},{"key":"bibr73-1074248413499971","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200933"}],"container-title":["Journal of Cardiovascular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248413499971","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1074248413499971","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248413499971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:39:31Z","timestamp":1777394371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1074248413499971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1177\/1074248413499971"],"URL":"https:\/\/doi.org\/10.1177\/1074248413499971","relation":{},"ISSN":["1074-2484","1940-4034"],"issn-type":[{"value":"1074-2484","type":"print"},{"value":"1940-4034","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}